Showing results (71-80 of 901) with videos related to

Sort By:
Pageof 91
Hepatology (Baltimore, Md.)|February 1, 2006
Autoimmune hepatitis, from mechanisms to therapyMichael P Manns, Arndt Vogel
Nature Reviews. Gastroenterology & Hepatology|May 20, 2022
Breakthroughs in hepatitis C research: from discovery to cureMichael P Manns, Benjamin Maasoumy
Liver International : Official Journal of the International Association for the Study of the Liver|January 5, 2013
Optimal treatment with boceprevir for chronic HCV infectionBenjamin Maasoumy, Michael P Manns
Nature Reviews. Gastroenterology & Hepatology|January 7, 2010
Epidemiology, pathogenesis and management of hepatitis D: update and challenges aheadHeiner Wedemeyer, Michael P Manns
The Journal of Antimicrobial Chemotherapy|September 9, 2008
Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alphaJohannes Wiegand, Katja Deterding, Markus Cornberg, et al.
Digestive Diseases (Basel, Switzerland)|October 19, 2012
NK cells in hepatitis C: role in disease susceptibility and therapySebastian Lunemann, Verena Schlaphoff, Markus Cornberg, et al.
Best Practice & Research. Clinical Gastroenterology|August 5, 2017
What is new on HBsAg and other diagnostic markers in HBV infection?Christoph Höner Zu Siederdissen, Benjamin Maasoumy, Markus Cornberg
Journal of Viral Hepatitis|September 7, 2018
New viral biomarkers for Hepatitis B: Are we able to change practice?Christoph Höner Zu Siederdissen, Benjamin Maasoumy, Markus Cornberg
Zeitschrift Fur Gastroenterologie|November 25, 2024
[Significant increase in newly diagnosed hepatitis B and C cases in Germany due to screening]Dietrich Hüppe, Yvonne Serfert, Markus Cornberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2018
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseasesAmare Aregay, Meike Dirks, Verena Schlaphoff, et al.
Pageof 91